Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signaling
Open Access
- 2 February 2024
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 150 (2) , 1-16
Abstract
Background: CCL11, a chemokine known for recruiting immune cells to the tumor microenvironment (TME), has an unclear role in the context of its expression, patient prognosis, and the presence of tumor-infiltrating immune cells (TILs) in breast cancer. Methods: The expression of CCL11 in invasive breast cancer (BRCA) was analyzed using TCGA database. Survival curve and Cox regression analysis determined the potential of CCL11 as an independent prognostic indicator. GSEA performed functional analysis on genes related to CCL11. CIBERSORT algorithm quantified the infiltration level of immune cells with varying CCL11 expression. Lastly, the correlation between CCL11 expression and anticancer drug sensitivity was examined. Immunohistochemistry (IHC) and qRT-PCR confirmed CCL11 expression in clinical tissue samples. The anti-tumor efficacy of CCL11 was investigated using CCK-8, plate formation, transwell assay, and Western blot. Results: CCL11 expression was elevated in BRCA tumor tissues compared to adjacent normal tissues. Recurrence-free survival (RFS) was longer in patients with high expression of CCL11. Enrichment and co-expression analyses revealed CCL11's association with numerous immune-related signaling pathways and genes. Validation studies confirmed high CCL11 expression in breast cancer tissues. In vitro experiments substantiated CCL11's anticancer effects in BRCA. Conclusion: CCL11 expression correlates with immune cell infiltration in breast cancer, indicating its potential as a prognostic biomarker for BRCA.Keywords
Funding Information
- Natural Science Foundation of Anhui Province of China (no.2008085QC112)
- Demonstration Project of Grassroots Teaching and Research Section in Anhui Province (2018jyssf035)
This publication has 39 references indexed in Scilit:
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression LevelsPLOS ONE, 2014
- Chemokines and Skin DiseasesArchivum Immunologiae et Therapiae Experimentalis, 2014
- Pattern response of dendritic cells in the tumor microenvironment and breast cancerWorld Journal of Clinical Oncology, 2014
- TNRC9 Downregulates BRCA1 Expression and Promotes Breast Cancer AggressivenessCancer Research, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The prognostic significance of B lymphocytes in invasive carcinoma of the breastBreast Cancer Research and Treatment, 2011
- CCL11–CCR3 Interactions Promote Survival of Anaplastic Large Cell Lymphoma Cells via ERK1/2 ActivationCancer Research, 2011
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammationJournal of Leukocyte Biology, 2009
- Role of Eotaxin-1 Signaling in Ovarian CancerClinical Cancer Research, 2009
- Chemokines in cancerCytokine & Growth Factor Reviews, 2002